125 related articles for article (PubMed ID: 3266711)
1. Inhibition of human chymotrypsin-like proteases by alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin.
Hayem A; Marko D; Laine A; Davril M
Adv Exp Med Biol; 1988; 240():97-9. PubMed ID: 3266711
[No Abstract] [Full Text] [Related]
2. In vivo catabolism of alpha 1-antichymotrypsin is mediated by the Serpin receptor which binds alpha 1-proteinase inhibitor, antithrombin III and heparin cofactor II.
Pizzo SV; Mast AE; Feldman SR; Salvesen G
Biochim Biophys Acta; 1988 Nov; 967(2):158-62. PubMed ID: 3263884
[TBL] [Abstract][Full Text] [Related]
3. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.
Duranton J; Adam C; Bieth JG
Biochemistry; 1998 Aug; 37(32):11239-45. PubMed ID: 9698370
[TBL] [Abstract][Full Text] [Related]
4. Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors.
Powers JC; Tanaka T; Harper JW; Minematsu Y; Barker L; Lincoln D; Crumley KV; Fraki JE; Schechter NM; Lazarus GG
Biochemistry; 1985 Apr; 24(8):2048-58. PubMed ID: 3893542
[TBL] [Abstract][Full Text] [Related]
5. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the interactions of human alpha1-antichymotrypsin with human leukocyte cathepsin G and bovine chymotrypsin.
Laine A; Davril M; Hayem A; Loucheux-Lefevbre AH
Biochem Biophys Res Commun; 1982 Jul; 107(1):337-44. PubMed ID: 6896992
[No Abstract] [Full Text] [Related]
7. Oxidation of alpha-1-proteinase inhibitor: significance for pathobiology.
Travis J; Beatty K; Matheson N
Adv Exp Med Biol; 1984; 167():89-95. PubMed ID: 6231839
[No Abstract] [Full Text] [Related]
8. Assay of complexed alpha 1-antichymotrypsin in plasma.
Heidtmann HH; Havemann K
Clin Chem; 1993 May; 39(5):869-74. PubMed ID: 8485879
[TBL] [Abstract][Full Text] [Related]
9. Differential recognition of alpha 1-antitrypsin-elastase and alpha 1-antichymotrypsin-cathepsin G complexes by the low density lipoprotein receptor-related protein.
Poller W; Willnow TE; Hilpert J; Herz J
J Biol Chem; 1995 Feb; 270(6):2841-5. PubMed ID: 7852358
[TBL] [Abstract][Full Text] [Related]
10. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters.
Oleksyszyn J; Powers JC
Biochemistry; 1991 Jan; 30(2):485-93. PubMed ID: 1988040
[TBL] [Abstract][Full Text] [Related]
11. Studies on inhibition of neutrophil cathepsin G by alpha 1-antichymotrypsin.
Patston PA
Inflammation; 1995 Feb; 19(1):75-81. PubMed ID: 7705888
[TBL] [Abstract][Full Text] [Related]
12. alpha 1-Antichymotrypsin in lung secretions is not an effective proteinase inhibitor.
Berman G; Afford SC; Burnett D; Stockley RA
J Biol Chem; 1986 Oct; 261(30):14095-9. PubMed ID: 3533915
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin.
Beatty K; Bieth J; Travis J
J Biol Chem; 1980 May; 255(9):3931-4. PubMed ID: 6989830
[TBL] [Abstract][Full Text] [Related]
14. Heparin protects cathepsin G against inhibition by protein proteinase inhibitors.
Ermolieff J; Boudier C; Laine A; Meyer B; Bieth JG
J Biol Chem; 1994 Nov; 269(47):29502-8. PubMed ID: 7961933
[TBL] [Abstract][Full Text] [Related]
15. DNA strongly impairs the inhibition of cathepsin G by alpha(1)-antichymotrypsin and alpha(1)-proteinase inhibitor.
Duranton J; Boudier C; Belorgey D; Mellet P; Bieth JG
J Biol Chem; 2000 Feb; 275(6):3787-92. PubMed ID: 10660528
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human serine proteases by SPAAT, the C-terminal 44-residue peptide from alpha1-antitrypsin.
Niemann MA; Baggott JE; Miller EJ
Biochim Biophys Acta; 1997 Jun; 1340(1):123-30. PubMed ID: 9217022
[TBL] [Abstract][Full Text] [Related]
17. "In vivo" and "in vitro" inhibition of human pancreatic chymotrypsin A by serum inhibitors.
Vercaigne-Marko D; Carrère J; Ducourouble MP; Davril M; Laine A; Amouric M; Figarella C; Hayem A
Biol Chem Hoppe Seyler; 1987 Jan; 368(1):37-45. PubMed ID: 2435303
[TBL] [Abstract][Full Text] [Related]
18. Interaction between human serum alpha 1-antichymotrypsin and human leukocyte cathepsin G. complex formation and production of a modified inhibitor.
Laine A; Davril M; Hayem A
Biochem Biophys Res Commun; 1982 Mar; 105(1):186-93. PubMed ID: 6980000
[No Abstract] [Full Text] [Related]
19. Isolation and properties of stachyrase A, a chymotrypsin-like serine proteinase from Stachybotrys chartarum.
Kordula T; Banbula A; Macomson J; Travis J
Infect Immun; 2002 Jan; 70(1):419-21. PubMed ID: 11748212
[TBL] [Abstract][Full Text] [Related]
20. Potent inactivator of alpha-chymotrypsin: 2,2-dimethyl-3-(N-4-cyanobenzoyl)amino-5-phenyl pentanoic anhydride.
Ito K; Igarashi K; Muramatsu M; Harada T; Hayashi Y; Katada J; Uno I
Biochem Biophys Res Commun; 1997 Nov; 240(3):850-5. PubMed ID: 9398657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
